[Phenotypic Variability and Therapeutic Progress in Mitochondrial Disorders].

Area of Science:

• Genetics
• Molecular Biology
• Biochemistry

Background:

• Mitochondrial diseases are inherited conditions originating from genetic mutations affecting either nuclear or mitochondrial DNA.
• These disorders disrupt cellular energy (ATP) production, leading to a broad spectrum of clinical manifestations.
• Significant phenotypic variability, even among individuals with identical genetic mutations, complicates diagnosis.

Purpose of the Study:

• To summarize the current understanding of mitochondrial diseases.
• To highlight the genetic basis and diagnostic challenges.
• To underscore the progress in identifying causative genes and developing new treatments.

Main Methods:

• Review of genetic databases and scientific literature.
• Analysis of reported causative genes and their associated pathologies.
• Examination of current research trends in therapeutic development.

Main Results:

• Over 400 genes implicated in mitochondrial diseases have been identified.
• Understanding of disease pathophysiology is continuously improving.
• Novel therapeutic strategies, including gene therapy, are under active development.

Conclusions:

• Mitochondrial diseases represent a complex group of genetic disorders with significant clinical heterogeneity.
• Continued research into gene function and pathophysiology is crucial for improving diagnosis and treatment.
• Emerging therapies hold promise for managing these debilitating conditions.